Australian infectious bronchitis viruses: identification of nine subtypes by a neutralisation test

The antigenic relationships between 17 Australian infectious bronchitis viruses, including six vaccine viruses, were studied by a neutralisation test using a plaque reduction method in chick embryo kidney cell monolayers. The 17 viruses formed nine distinct subtypes. Antiserum to each subtype had a high titre to viruses of the same subtype and a lower titre to viruses of different subtypes. The heterologous titres of sera varied widely.     

Serologic and cross-protection studies with several infectious bronchitis virus isolates from Delmarva-reared broiler chickens

Five isolates, from broiler-type chickens, capable of causing acute respiratory disease were identified as infectious bronchitis virus (IBV). The agar-gel precipitin (AGP) test was effective in identifying the isolates as IBV. Virus-neutralization (VN) and cross-challenge tests indicated two of the isolates to be Massachusetts types and one to be a JMK type. The remaining isolates were different from strains normally encountered in chickens reared on the Delmarva Peninsula. One isolate, although serologically similar to the Connecticut strain, was able to infect Connecticut-virus-immune chickens. Another isolate was similar to Arkansas 99, a strain not previously reported in Delmarva.     

Avian infectious bronchitis virus in Africa: a review

Infectious bronchitis virus (IBV) is worldwide in distribution, highly infectious, and extremely difficult to control because it has extensive genetic diversity, a short generation time, and a high mutation rate. IBV is a Gammacoronavirus, single-stranded, and positive-sense RNA virus. Avian infectious bronchitis is well studied in European countries with identification of a large number of IBV variants, whereas in African countries epidemiological and scientific data are poor and not updated. However, previous studies reported that an IBV variant continues to appear regularly in Africa, as currently described in Morocco. No cross-protection between IBV strains was reported, some being unique to a particular country, others having a more general distribution. This review aims to provide a general overview on IB disease distribution in African countries and an update on the available studies of IBV variants in each country.     

鸡传染性支气管炎实验室诊断方法研究进展

传染性支气管炎是鸡的一种重大传染病,临床上无典型的病变特征,诊断较为困难。现有的实验室检测方法有血清学、病原学和分子生物学方法,但该病病原变异复杂,血清型众多,交叉免疫性低,临床上又多采用活毒进行免疫,以至实验室无法对疫苗毒和野毒进行准确区分。为了更好地控制本病,有必要根据临床特点对目前各种检测鸡传染性支气管炎的方法及其优缺点进行分析,为临床寻找一种适合的快速准确的诊断方法、制定合理的免疫程序和发展新型的诊断方法提供参考。     

禽传染性支气管炎病毒S基因的研究进展

作为严重危害养禽业的禽传染性支气管炎病毒(IBV),正受到兽医界的普遍关注。文章就人们在分子生物学领域对IBV S基因的结构特征、免疫活性、与病毒血清的关系、基因工程疫苗等方面的研究概况作了综述,并且根据病毒与热休克蛋白(HSPS)之阃相互作用,设想使IBV的S基因与HSPS结合,开发出一种新型高效的IBV疫苗。     

鸡传染性支气管炎病毒SH株的分离及鉴定

从黑龙江省绥化市某养鸡场疑似鸡传染性支气管炎的鸡群中采集病料,经鸡胚传代、电镜观察、生物学特性和分子生物学鉴定以及动物回归试验,表明该分离株具有明显的鸡传染性支气管炎病毒特征,具有鸡胚出现卷曲、出血、发育延迟等作用;对新城疫病毒有明显的干扰作用;动物回归试验导致未免疫鸡出现明显的感染症状,剖检可见明显的肾脏肿胀、尿酸盐沉积现象,同时可见呼吸道有出血现象。对该毒株的N基因进行扩增,并将其序列与NCBI的参考毒株的N基因进行序列对比,发现其与国内的分离株SC和N毒株的N基因具有较高的同源性,为97.6%;与国外参考毒株和国内的疫苗株同源性较低,为84.8%。表明分离的病毒为鸡传染性支气管炎病毒。     

肾型鸡传染性支气管炎病毒新疆株的生物学特性研究

通过致病力试验和免疫原性检测对肾型鸡传染性支气管炎病毒新疆株(IBVXJ-2株)进行生物学特性的研究。致病力检测结果证实,IBVXJ-2株可以致SPF鸡胚卷缩、僵化,EID50达10-8.3/0.1 mL;鸡胚肾细胞在接毒后96 h出现皱缩、脱落等明显的细胞病变;对20日龄非免疫鸡攻毒后第2天,试验鸡出现甩鼻、伸颈张口呼吸等症状。将IBVXJ-2株抗原经乳化后接种1月龄非免疫鸡,在接种后22 d和44 d用ELISA和HI检测到了IBV特异性抗体。     

Avian infectious bronchitis virus: a possible cause of reduced fertility in the rooster

The formation of epididymal stones in the rooster epididymis is a widespread problem that has detrimental effects on sperm production and fertility. The cause of epididymal stones is unknown, but an infectious agent, the avian infectious bronchitis virus (AIBV), has been implicated. The goal of this study was to determine if administering the live attenuated AIBV vaccine to male chicks increases the incidence of stones in the epididymal region of the adult rooster. Specific pathogen free (SPF) Leghorn roosters were divided into two groups: a vaccine-free group (n = 7) and a group vaccinated with AIBV (n = 12). The vaccine was administered orally at 2, 4, 10, and 14 wk of age. Blood was drawn weekly to monitor antibodies to AIBV. At 26 wk of age, blood was obtained to determine testosterone concentrations, and reproductive tracts were removed to analyze daily sperm production and to detect epididymal stones. Nine of 12 vaccinated roosters developed stones, whereas those not given the vaccine did not develop stones. Serum testosterone concentrations were significantly (P < 0.05) reduced in vaccinated roosters with epididymal stones (3.6 +/- 0.30 ng/ml) when compared with nonvaccinated roosters that did not have epididymal stones (7.0 +/- 1.63 ng/ml). Testis weight was significantly (P < 0.05) reduced in vaccinated roosters with epididymal stones (12.1 +/- 0.76 g), as compared with nonvaccinated roosters without epididymal stones (15.2 +/- 0.81 g). Daily sperm production was significantly (P < 0.05) decreased in vaccinated roosters with epididymal stones (5.03 +/- 0.31 x 10(8) sperm/testis/day) when compared with nonvaccinated roosters without epididymal stones (7.43 +/- 0.52 x 10(8) sperm/testis/day). Comparing daily sperm production on a per gram basis, vaccinated roosters with epididymal stones had 4.38 +/- 0.14 x 10(7) sperm/g of testis, which was significantly (P < 0.05) smaller than nonvaccinated roosters without epididymal stones, which had 5.17 +/- 0.17 x 10(7) sperm/g of testis. We conclude that the use of a live attenuated AIBV vaccine increases the incidence of epididymal stones in roosters, resulting in decreased sperm production and decreased serum testosterone concentrations.     

Characterization of infectious bronchitis virus using monoclonal antibodies

Three monoclonal antibodies (MABs) reactive against two structural proteins--the nucleoprotein (NP) or the surface (S) protein--of avian infectious bronchitis virus (IBV) were produced and characterized. The MABs did not neutralize virus infectivity or inhibit hemagglutination. Their reactivity patterns with the homologous strain and eight heterologous strains of IBV were determined using the indirect immunoperoxidase test, the indirect immunofluorescent test, transfer-immunoblotting of separated proteins, and a dot-immunoblotting assay (DIA). Two MABs, NP- or S-protein-specific, reacted with all nine strains; one (NP-specific) reacted with only two strains. The two MABs reacting with all nine strains of IBV also detected 18 IBV field isolates of unknown serotype in the DIA. The MAB detecting only two strains did not react in the DIA. The diagnostic application of these MABs appears promising.     

鸡传染性支气管炎病毒S1和N基因遗传变异的相关性

对国内1992—2005年分离的IBV毒株的纤突蛋白(S1)和核衣壳蛋白(N)基因分别进行克隆测序,结合在GenBank中发表的IBV S1和N基因的序列,对其不同毒株的S1或N基因片段和全长、S1和N基因全长分别进行遗传变异的研究,利用统计学软件SPSS11.5进行同源性相关分析。结果表明:不同IBV毒株N或S1基因片段与其全长之间遗传变异高度相关,核苷酸r≥0.892,氨基酸0.854≤r≤0.968;但S1与N基因全长之间核苷酸的遗传变异相关性相对较低一些,而且有些毒株间S1基因同源性很低(r=0.645),但N基因同源性仍很高,显示每个基因变异的独立性。国内IBV疫苗株之间S1和N基因核苷酸高度同源(S1≥97.3%;N≥90.7%),而野毒株与疫苗株相比S1和N基因同源性均较低(S1≤84.3%;N≤87.1%),这也可能与常规疫苗对IBV野毒株不能有效保护有关。